Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation

Medical Condition

Chronic Obstructive Pulmonary Disease (COPD)

Facility/Clinic

PMG Research of Wilmington

Age

40-80

Gender

Male/Female

Description

A research study is evaluating the effects of an investigational medication for COPD when added to standard-of-care treatment in adults needing additional therapy.

This research study may be an option if you: 

• Have been diagnosed with moderate to severe COPD for more than 1 year

• Are a current or former smoker 

• Have evidence of type 2 inflammation of the airways 

• Have experienced symptoms of chronic bronchitis for at least 3 months in the past year (productive cough, shortness of breath, wheezing, chest tightness)

• Are at a high risk of exacerbation with a history of 1 or 2 moderate or severe exacerbations in the last year

Other criteria apply.  Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and study medication (including standard of care treatment) at no cost.

Enrollment

Open

Patient Commitment Duration

Approximately 16 months

Patient Compensation

Financial compensation may be provided for time and travel expenses.  

Number of visits in study

Approximately 19 clinic visits